Development of Autoimmune Hypothyroidism after Interferon-beta 1a Treatment in Patient with Multiple Sclerosis: A Case Report | Zendy

MA Awal | Zendy; Md Sunny Anam Chowdhury | Zendy; Md Hafizur Rahman | Zendy

Open Access

Development of Autoimmune Hypothyroidism after Interferon-beta 1a Treatment in Patient with Multiple Sclerosis: A Case Report

Author(s) -

MA Awal,

Md Sunny Anam Chowdhury,

Md Hafizur Rahman

Publication year - 2018

Publication title -

bangladesh journal of nuclear medicine

Language(s) - English

Resource type - Journals

ISSN - 1562-3831

DOI - 10.3329/bjnm.v19i2.36014

Subject(s) - multiple sclerosis , medicine , interferon beta , autoimmune disease , interferon , demyelinating disease , immunology , central nervous system , disease

Interferon beta therapy is a well-established treatment of patients suffering from multiple sclerosis, a demyelinating disease of the central nervous system. Since type I interferons have immunomodulatory properties, these cytokines may trigger several autoimmune disorders. In this case, we report the development of autoimmune hypothyroidism in a multiple sclerosis patients receiving interferon-β 1a. Bangladesh J. Nuclear Med. 19(2): 149-151, July 2016

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research